Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Change in Receivables: 2020-2023

Historic Change in Receivables for Relay Therapeutics (RLAY) over the last 4 years, with Dec 2023 value amounting to -$306,000.

  • Relay Therapeutics' Change in Receivables fell 424.62% to -$211,000 in Q4 2023 from the same period last year, while for Dec 2023 it was -$306,000, marking a year-over-year decrease of 215.46%. This contributed to the annual value of -$306,000 for FY2023, which is 215.46% down from last year.
  • Relay Therapeutics' Change in Receivables amounted to -$306,000 in FY2023, which was down 215.46% from -$97,000 recorded in FY2022.
  • In the past 5 years, Relay Therapeutics' Change in Receivables ranged from a high of $75.0 million in FY2020 and a low of -$74.7 million during FY2021.
  • Its 3-year average for Change in Receivables is -$25.0 million, with a median of -$306,000 in 2023.
  • In the last 5 years, Relay Therapeutics' Change in Receivables soared by 99.87% in 2022 and then tumbled by 215.46% in 2023.
  • Over the past 4 years, Relay Therapeutics' Change in Receivables (Yearly) stood at $75.0 million in 2020, then slumped by 199.57% to -$74.7 million in 2021, then soared by 99.87% to -$97,000 in 2022, then crashed by 215.46% to -$306,000 in 2023.